Company

The Institute of Applied Biotechnologies Inc. (IAB) has been established in 2005 with focus on research, development and the manufacturing of products for molecular biotechnologies. In 2014 NGS laboratories were set up and IAB became the provider of services for different types of NGS projects. Currently, IAB is a team of experts specializing in next-generation sequencing and bioinformatics, all under one roof to provide a complete NGS solution using state of the art technologies.

IAB provides a wide range of services for genomic analyses using “Next Generation Sequencing (NGS)” technologies. We use the most modern bioinformatics analytical procedures to process large genomic and genetic data for accurate and consistent interpretation of NGS results. We provide services to both public and private healthcare and research partners.

The mission of IAB is to become a reliable provider of innovative, scalable and flexible NGS services to meet the needs of customers involved in projects of different types and to enable researchers to explore DNA on a new scale, thus helping them to move their research to another level.